Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

被引：0
|
作者：
Ragne K. Farmen
Oddmund Nordgård
Bjørnar Gilje
Fuad V. Shammas
Jan T. Kvaløy
Satu Oltedal
Reino Heikkilä
机构：
[1] Stavanger University Hospital,Department of Hematology and Oncology
[2] University of Stavanger,Department of Mathematics and Natural Science
[3] Stavanger University Hospital,Division of Research and Human Resources
[4] Gena AS,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Breast cancer; Bone marrow; Micrometastases; Real-time RT-PCR; Cytokeratin 19; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：7
相关论文
共 50 条
  • [1] Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients
    Farmen, Ragne K.
    Nordgard, Oddmund
    Gilje, Bjornar
    Shammas, Fuad V.
    Kvaloy, Jan T.
    Oltedal, Satu
    Heikkilae, Reino
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 251 - 258
  • [2] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Agelaki, S.
    Perraki, M.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Kontopodis, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 589 - 597
  • [3] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    A Daskalaki
    S Agelaki
    M Perraki
    S Apostolaki
    N Xenidis
    E Stathopoulos
    E Kontopodis
    D Hatzidaki
    D Mavroudis
    V Georgoulias
    British Journal of Cancer, 2009, 101 : 589 - 597
  • [4] Detection of cytokeratin-19 mRNA-positive cells in peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Perraki, M.
    Agelaki, S.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 112 - 112
  • [5] Bone marrow micrometastasis significantly impacts on survival and relapse free survival in patients with breast cancer
    Faul, EM
    Kelly, M
    Aherne, N
    Redmond, K
    Relihan, N
    Wang, J
    Kelly, J
    Richardson, N
    O'Hanlon, D
    Redmond, P
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (03) : S85 - S86
  • [6] Clusterin Overexpression and Relapse-free Survival in Breast Cancer
    Yom, Cha Kyong
    Woo, Hee-Yeon
    Min, Sun Young
    Kang, So Young
    Kim, Hee Sung
    ANTICANCER RESEARCH, 2009, 29 (10) : 3909 - 3912
  • [7] Bone marrow micrometastasis is a significant predictor of long-term relapse-free survival for breast cancer by a non-proportional hazards model.
    Wong, GYC
    Yu, Q
    Osborne, MP
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S99 - S99
  • [8] Inflammatory breast carcinoma signature and relapse-free survival in patients with noninflammatory breast cancer
    Van Laere, S. J.
    Van den Eynden, G. G.
    Van der Auwera, I.
    Trinh, X. B.
    van Dam, P. A.
    Van Marck, E. A.
    Vermeulen, P. B.
    Dirix, L. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A system to estimate relapse-free survival probabilities and probable benefit from adjuvant therapy in patients with operable breast cancer.
    Miles, DW
    Ryder, K
    Rubens, RD
    Royston, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S69 - S69
  • [10] Disseminated Tumor Cells in Bone Marrow Assessed by TWIST1, Cytokeratin 19, and Mammaglobin A mRNA Predict Clinical Outcome in Operable Breast Cancer Patients
    Tjensvoll, Kjersti
    Oltedal, Satu
    Farmen, Ragne K.
    Shammas, Fuad V.
    Heikkila, Reino
    Kvaloy, Jan T.
    Gilje, Bjornar
    Smaaland, Rune
    Nordgard, Oddmund
    CLINICAL BREAST CANCER, 2010, 10 (05) : 378 - 384
12345